Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Durable Equipment Groups Continue To Seek Competitive Bidding Revamp

This article was originally published in The Gray Sheet

Executive Summary

Durable medical equipment suppliers, wholesalers and retail outlets continue to push for major changes to how CMS administers its competitive bidding program for durable medical equipment, prosthetics, orthotics and supplies

You may also be interested in...



DME Suppliers Down 27 Percent In Competitive Bidding Areas In 2012 – GAO

Durable medical equipment suppliers dropped by 27 percent in Medicare competitive bidding areas while only 5 percent of DME suppliers were lost in comparable, non-bidding areas. But the second year of the program’s round 1 rebid in 2012 saved Medicare $400 million, according to a newly-released Government Accountability Office report.

DME Suppliers Await CBO Score On Competitive Bidding Alternative

Durable medical equipment supplier groups pressed their “Market Pricing Program” during a May 9 House subcommittee hearing as an alternative to the Medicare competitive bidding program. The Congressional Budget Office is currently analyzing the proposal.

As DME Bidding Program Rolls Ahead, Auction Researchers Call It “Fatally Flawed”

CMS is moving forward as planned with a 10-fold expansion in the number of metropolitan areas where Medicare will pay for popular durable medical equipment at reduced, competitively bid rates.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027261

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel